Phase 3b data show centanafadine reduces adult ADHD and comorbid anxiety.
|Slideshows|May 18, 2017
7 Medical Illnesses That May Present as Anxiety
Beyond psychosocial implications of anxiety disorders, an array of physiological effects may ensue.
Advertisement
To view a PDF, of this slideshow, click here.
Advertisement
Related to this article
How tuning body signals with closed-loop sound and chill tech may ease dissociation and anhedonia, offering drug-free add-ons to therapy.
Single-dose DT120 ODT delivers rapid, sustained anxiety relief in phase 3 GAD trial, supporting FDA breakthrough path and NDA plans.
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Top 7 Atypical Psychedelics: A Brief Clinical Guide
2
Positive Topline Phase 3 Study Results: Lumateperone for Manic Episodes in Bipolar I Disorder
3
Phase 1 Data: SNTX-2643 Blunts the Brain's Stress Response After a Single Dose
4
New Analyses of HLP003 for the Adjunctive Treatment of MDD
5